Use of mesenchymal stem cells for cutaneous repair and skin substitute elaboration

Pathologie Biologie

Volumn 62, Issue 2, 2014, Pages 108-117

  Laverdet, B ^a   Micallef, L ^a   Lebreton, C ^b   Mollard, J ^c   Lataillade, J J ^d   Coulomb, B ^e   Desmouliere A ^a  

^a UNIVERSITY OF LIMOGES   (France)

^b INSERM   (France)

^c DUPUYTREN UNIVERSITY HOSPITAL   (France)

^d Centre de Transfusion Sanguine des Armees   (France)

^e PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

(Myo)fibroblasts; Mesenchymal stem cells; Reconstituted skin; Tissue repair

Indexed keywords

COLLAGEN; MATRIX METALLOPROTEINASE;

ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ARTICLE; ARTIFICIAL SKIN; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BURN; DERMAL TISSUE DERIVED MESENCHYMAL STEM CELL; ENZYME RELEASE; EPIDERMIS; EXTRA FETAL TISSUE DERIVED MESENCHYMAL STEM CELL; GINGIVAL TISSUE DERIVED MESENCHYMAL STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; SKIN ALLOGRAFT; SKIN AUTOGRAFT; SKIN DEFECT; SKIN FIBROBLAST; SKIN REPAIR; THERAPY EFFECT; TISSUE DIFFERENTIATION; TISSUE REPAIR; WOUND HEALING; ANTIBODY SPECIFICITY; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DERMIS; ENZYMOLOGY; FIBROBLAST; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES; SKIN; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRANSPLANTATION; WOUND CLOSURE;

CELL DIFFERENTIATION; CELLS, CULTURED; DERMIS; EPIDERMIS; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; ORGAN SPECIFICITY; SKIN; SKIN, ARTIFICIAL; TISSUE ENGINEERING; TISSUE SCAFFOLDS; WOUND CLOSURE TECHNIQUES; WOUND HEALING;

EID: 84898417889     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2014.01.002     Document Type: Article

References (114)

1. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature 2008, 453:314-321.
2. Velnar T., Bailey T., Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009, 37:1528-1542.
3. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
4. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
5. Shaw T.J., Martin P. Wound repair at a glance. J Cell Sci 2009, 122:3209-3213.
6. Vedrenne N., Coulomb B., Danigo A., Bonté F., Desmoulière A. The complex dialogue between (myo)fibroblasts and the extracellular matrix during skin repair processes and ageing. Pathol Biol 2012, 60:20-27.
7. Desmoulière A., Redard M., Darby I., Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995, 146:56-66.
8. Guo S., Dipietro L.A. Factors affecting wound healing. J Dent Res 2010, 89:219-229.
9. Maxson S., Lopez E.A., Yoo D., Danilkovitch-Miagkova A., LeRoux M.A. Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Trans Med 2012, 1:142-149.
10. Bruder S.P., Jaiswal N., Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997, 64:278-294.
11. Prockop D.J. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 1997, 276:71-74.
12. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006, 98:1076-1084.
13. Caplan A.I. Why are MSCs therapeutic? New data: new insight. J Pathol 2009, 217:318-324.
14. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
15. Friedenstein A.J., Piatetzky-Shapiro I.I., Petrakova K.V. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966, 16:381-390.
16. Owen M., Friedenstein A.J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988, 136:42-60.
17. Doucet C., Ernou I., Zhang Y., Llense J.R., Begot L., Holy X., et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005, 205:228-236.
18. Bieback K., Hecker A., Kocaömer A., Lannert H., Schallmoser K., Strunk D., et al. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009, 27:2331-2341.
19. De Ugarte D.A., Morizono K., Elbarbary A., Alfonso Z., Zuk P.A., Zhu M., et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003, 174:101-109.
20. Estes B.T., Diekman B.O., Gimble J.M., Guilak F. Isolation of adipose derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 2010, 5:1294-1311.
21. Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., Noort W.A., Claas F.H., Willemze R., et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003, 102:1548-1549.
22. Roubelakis M.G., Trohatou O., Anagnou N.P. Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int 2012, 36:1078.
23. Cipriani S., Bonini D., Marchina E., Balgkouranidou I., Caimi L., Grassi Zucconi G., et al. Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain. Cell Biol Int 2007, 31:845-850.
24. Lo Iacono M., Anzalone R., Corrao S., Giuffrè M., Di Stefano A., Giannuzzi P., et al. Perinatal and wharton's jelly-derived mesenchymal stem cells in cartilage regenerative medicine and tissue engineering strategies. Open Tissue Eng Regen Med J 2011, 4:72-81.
25. Tam K., Suganya C., Venugopal J., Biswas A., Choolani M., Ramakrishna S., et al. A nanoscaffold impregnated with human wharton's jelly stem cells or its secretions improves healing of wounds. J Cell Biochem 2014, 115:794-803.
26. Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004, 22:649-658.
27. Yen B.L., Huang H.I., Chien C.C., Jui H.-Y., Ko B.-S., Yao M., et al. Isolation of multipotent cells from human term placenta. Stem Cells 2005, 23:3-9.
28. Schmidt D., Mol A., Breymann C., Achermann J., Odermatt B., Gössi M., et al. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation 2006, 114(Suppl. 1):I125-I131.
29. Whittle W.L., Gibb W., Challis J.R.G. The characterization of human amnion epithelial and mesenchymal cells: the cellular expression, activity and glucocorticoid regulation of prostaglandin output. Placenta 2000, 21:394-401.
30. Kmiecik G., Niklińska W., Kuć P., Pancewicz-Wojtkiewicz J., Fil D., Karwowska A., et al. Fetal membranes as a source of stem cells. Adv Med Sci 2013, 58:1-11.
31. Miki T., Lehmann T., Cai H., Stolz D.B., Strom S.C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005, 23:1549-1559.
32. Manochantr S., Tantrawatpan C., Kheolamai P., U-pratya Y., Supokawej A., Issaragrisil S. Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells. J Med Assoc Thai 2010, 93(Suppl. 7):S183-S191.
33. Tamagawa T., Oi S., Ishiwata I., Ishikawa H., Nakamura Y. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell 2007, 20:77-84.
34. Marcus A.J., Coyne T.M., Rauch J., Woodbury D., Black I.B. Isolation, characterization, and differentiation of stem cells derived from the rat amniotic membrane. Differentiation 2008, 76:130-144.
35. Tomar G.B., Srivastava R.K., Gupta N., Barhanpurkar A.P., Pote S.T., Jhaveri H.M., et al. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem Biophys Res Commun 2010, 393:377-383.
36. Fournier B.P., Ferre F.C., Couty L., Lataillade J.J., Gourven M., Naveau A., et al. Multipotent progenitor cells in gingival connective tissue. Tissue Eng Part A 2010, 16:2891-2899.
37. Mitrano T.I., Grob M.S., Carrión F., Nova-Lamperti E., Luz P.A., Fierro F.S., et al. Culture and characterization of mesenchymal stem cells from human gingival tissue. J Periodontol 2010, 81:917-925.
38. Naveau A., Lataillade J.J., Fournier B.P., Couty L., Prat M., Ferre F.C., et al. Phenotypic study of human gingival fibroblasts in a medium enriched with platelet lysate. J Periodontol 2011, 82:632-641.
39. Zhang Q., Shi S., Liu Y., Uyanne J., Shi Y., Shi S., et al. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 2009, 183:7787-7798.
40. Zhang Q., Nguyen A.L., Shi S., Hill C., Wilder-Smith P., Krasieva T.B., et al. Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis. Stem Cells Dev 2012, 21:937-947.
41. Gogly B., Naveau A., Fournier B., Reinald N., Durand E., Brasselet C., et al. Preservation of rabbit aorta elastin from degradation by gingival fibroblasts in an ex vivo model. Arterioscler Thromb Vasc Biol 2007, 27:1984-1990.
42. Durand E., Fournier B., Couty L., Lemitre M., Achouh P., Julia P., et al. Endoluminal gingival fibroblast transfer reduces the size of rabbit carotid aneurisms via elastin repair. Arterioscler Thromb Vasc Biol 2012, 32:1892-1901.
43. Séguier S., Tartour E., Guérin C., Couty L., Lemitre M., Lallement L., et al. Inhibition of the differentiation of monocyte-derived dendritic cells by human gingival fibroblasts. PLoS One 2013, 8:e77093.
44. Rheinwald J.G., Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975, 6:331-343.
45. Barrandon Y., Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci U S A 1987, 84:2302-2306.
46. Li L., Mignone J., Yang M., Matic M., Penman S., Enikolopov G., et al. Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci U S A 2003, 100:9958-9961.
47. Jahoda C.A., Whitehouse J., Reynolds A.J., Hole N. Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp Dermatol 2003, 12:849-859.
48. Amoh Y., Li L., Campillo R., Kawahara K., Katsuoka K., Penman S., et al. Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A 2005, 102(4):1773-1778.
49. Toma J.G., Akhavan M., Fernandes K.J.L., Barnabé-Heider F., Sadikot A., Kaplan D.R., et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001, 3:778-784.
50. Young H.E., Steele T.A., Bray R.A., Hudson J., Floyd J.A., Hawkins K., et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001, 264:51-62.
51. Toma J.G., McKenzie I.A., Bagli D., Miller F.D. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005, 23:727-737.
52. Lebonvallet N., Boulais N., Le Gall C., Chéret J., Pereira U., Mignen O., et al. Characterization of neurons from adult human skin-derived precursors in serum-free medium: a PCR array and immunocytological analysis. Exp Dermatol 2012, 21:195-200.
53. Higashiyama R., Nakao S., Shibusawa Y., Ishikawa O., Moro T., Mikami K., et al. Differential contribution of dermal resident and bone marrow-derived cells to collagen production during wound healing and fibrogenesis in mice. J Invest Dermatol 2011, 131:529-536.
54. Nakamura M., Tokura Y. Epithelial-mesenchymal transition in the skin. J Dermatol Sci 2011, 61:7-13.
55. Jahoda C.A., Reynolds A.J. Hair follicle dermal sheath cells: unsung participants in wound healing. Lancet 2001, 358:1445-1448.
56. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
57. Opalenik S.R., Davidson J.M. Fibroblast differentiation of bone marrow-derived cells during wound repair. FASEB J 2005, 19:1561-1563.
58. Direkze N.C., Forbes S.J., Brittan M., Hunt T., Jeffery R., Preston S.L., et al. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 2003, 21:514-520.
59. Micallef L., Vedrenne N., Coulomb B., Lataillade J.J., Desmoulière A. Use of mesenchymal stem/stromal cells in skin repair. J Wound Technol 2011, 13:72-77.
60. Fathke C., Wilson L., Hutter J., Kapoor V., Smith A., Hocking A., et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells 2004, 22:812-822.
61. Ishii G., Sangai T., Sugiyama K., Ito T., Hasebe T., Endoh Y., et al. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells 2005, 23:699-706.
62. Liu P., Deng Z., Han S., Liu T., Wen N., Lu W., et al. Tissue-engineered skin containing mesenchymal stem cells improves burn wounds. Artif Organs 2008, 32:925-931.
63. Falanga V., Iwamoto S., Chartier M., Yufit T., Butmarc J., Kouttab N., et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007, 13:1299-1312.
64. Yoshikawa T., Mitsuno H., Nonaka I., Sen Y., Kawanishi K., Inada Y., et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 2008, 121:860-877.
65. Lu D., Chen B., Liang Z., Deng W., Jiang Y., Li S., et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract 2011, 92:26-36.
66. Kim M., Kim I., Lee S.K., Bang S.I., Lim S.Y. Clinical trial of autologous differentiated adipocytes from stem cells derived from human adipose tissue. Dermatol Surg 2011, 37:750-759.
67. Fong C.Y., Tam K., Cheyyatraivendran S., Gan S.U., Gauthaman K., Armugam A., et al. Human umbilical cord Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds. J Cell Biochem 2014, 115:290-302.
68. Bey E., Duhamel P., Lataillade J.J., de Revel T., Carsin H., Gourmelon P. Treatment of radiation burns with surgery and cell therapy. A report of two cases. Bull Acad Natl Med 2007, 191:971-978.
69. Bey E., Prat M., Duhamel P., Benderitter M., Brachet M., Trompier F., et al. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen 2010, 18:50-58.
70. Bargues L., Prat M., Leclerc T., Bey E., Lataillade J.J. Present and future of cell therapy in burns. Pathol Biol (Paris) 2011, 59:e49-e56.
71. Lataillade J.J., Doucet C., Bey E., Carsin H., Huet C., Clairand I., et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2007, 2:785-794.
72. Schneider R.K., Anraths J., Kramann R., Bornemann J., Bovi M., Knüchel R., et al. The role of biomaterials in the direction of mesenchymal stem cell properties and extracellular matrix remodelling in dermal tissue engineering. Biomaterials 2010, 31:7948-7959.
73. Nie C., Yang D., Morris S.F. Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing. Med Hypotheses 2009, 72:679-682.
74. Sahin I., Ozturk S., Deveci M., Ural A.U., Onguru O., Isik S. Experimental assessment of the neo-vascularisation of acellular dermal matrix in the wound bed pretreated with mesenchymal stem cell under subatmospheric pressure. J Plastic Reconstr Aesthet Surg 2013, in press.
75. Chen L., Tredget E.E., Wu P.Y., Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008, 3:e1886.
76. Kode J.A., Mukherjee S., Joglekar M.V., Hardikar A.A. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009, 11:377-391.
77. Yang S.H., Park M.J., Yoon I.H., Kim S.Y., Hong S.H., Shin J.Y., et al. Soluble mediators from mesenchymal stem cells suppress T-cell proliferation by inducing IL-10. Exp Mol Med 2009, 41:315-324.
78. Spaggiari G.M., Capobianco A., Abdelrazik H., Becchetti F., Mingari M.C., Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008, 111:1327-1333.
79. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
80. Krasnodembskaya A., Song Y., Fang X., Gupta N., Serikov V., Lee J.-W., et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010, 28:2229-2238.
81. Mei S.H.J., Haitsma J.J., Dos Santos C.C., Deng Y., Lai P.F.H., Slutsky A.S., et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010, 182:1047-1057.
82. Krisp C., Jacobsen F., McKay M.J., Molloy M.P., Steinstraesser L., Wolters D.A. Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients. Proteomics 2013, 13:2670-2681.
83. Janeczek Portalska K., Leferink A., Groen N., Fernandes H., Moroni L., van Blitterswijk C., et al. Endothelial differentiation of mesenchymal stromal cells. Plos One 2012, 7:e46842.
84. Roura S., Bago J.R., Soler-Botija C., Pujal J.M., Galvez-Monton C., Prat-Vidal C., et al. Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo. Plos One 2012, 7:e49447.
85. Wu Y., Chen L., Scott P.G., Tredget E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem cells 2007, 25:2648-2659.
86. Wang Y., Crisostomo P.R., Wang M., Markel T.A., Novotny N.M., Meldrum D.R. TGF-β increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms. Am J Physiol Regul Integr Comp Physiol 2008, 295:R1115-R1123.
87. Sorrell J.M., Baber M.A., Caplan A.I. Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A 2009, 15:1751-1761.
88. Herrmann J.L., Weil B.R., Abarbanell A.M., Wang Y., Poynter J.A., Manukyan M.C., et al. IL-6 and TGF-α costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms. Shock 2011, 35:512-516.
89. Lu F., Mizuno H., Uysal C.A., Cai X., Ogawa R., Hyakusoku H. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg 2008, 121:50-58.
90. Smith A.N., Willis E., Chan V.T., Muffley L.A., Isik F.F., Gibran N.S., et al. Mesenchymal stem cells induce dermal fibroblast responses to injury. Exp Cell Res 2010, 316:48-54.
91. Wu Y., Huang S., Enhe J., Ma K., Yang S., Sun T., et al. Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice. Int Wound J 2013, [In press]. 10.1111/iwj.12034.
92. Németh K., Leelahavanichkul A., Yuen P.S., Mayer B., Parmelee A., Doi K., et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009, 15:42-49. [Erratum in Nat Med 2009;15:462].
93. Liechty K.W., Kim H.B., Adzick N.S., Crombleholme T.M. Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J Pediatr Surg 2000, 35:866-873.
94. Yu Y., Lu L., Qian X., Chen N., Yao A., Pu L., et al. Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats. Stem Cells Dev 2010, 19:903-914.
95. Bevan D., Gherardi E., Fan T.P., Edwards D., Warn R. Diverse and potent activities of HGF/SF in skin wound repair. J Pathol 2004, 203:831-838.
96. Mou S., Wang Q., Shi B., Gu L., Ni Z. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts. Kaohsiung J Med Sci 2009, 25:577-587.
97. Bell E., Sher S., Hull B., Merrill C., Rosen S., Chamson A., et al. The reconstitution of living skin. J Invest Dermatol 1983, 81:2s-10s.
98. Coulomb B., Friteau L., Baruch J., Guilbaud J., Chretien-Marquet B., Glicenstein J., et al. Advantage of the presence of living dermal fibroblasts within in vitro reconstructed skin for grafting in humans. Plast Reconstr Surg 1998, 101:1891-1903.
99. Coulomb B., Lebreton C., Dubertret L. Influence of human dermal fibroblasts on epidermalization. J Invest Dermatol 1989, 92:122-125.
100. Asselineau D., Bernard B.A., Bailly C., Darmon M. Retinoic acid improves epidermal morphogenesis. Dev Biol 1989, 33:322-335.
101. Sanquer S., Coulomb B., Lebreton C., Dubertret L. Human dermal fibroblasts modulate the effects of retinoids on epidermal growth. J Invest Dermatol 1990, 95:700-704.
102. Wha Kim S., Lee I.W., Cho H.J., Cho K.H., Han Kim K., Chung J.H., et al. Fibroblasts and ascorbate regulate epidermalization in reconstructed human epidermis. J Dermatol Sci 2002, 30:215-223.
103. Boyce S.T., Warden G.D. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 2002, 183:445-456.
104. Sensebe L., Bourin P., Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 2011, 22:19-26.
105. Coulomb B., Dubertet L., Merrill C., Touraine R., Bell E. The collagen lattice: a model for studying the physiology, biosynthetic function and pharmacology of the skin. Br J Dermatol 1984, 111(Suppl 27):83-87.
106. Coulomb B., Saiag P., Bell E., Breitburd F., Lebreton C., Heslan M., et al. A new method for studying epidermalization in vitro. Br J Dermatol 1986, 114:91-101.
107. Fioretti F., Lebreton-DeCoster C., Gueniche F., Yousfi M., Humbert P., Godeau G., et al. Human bone marrow-derived cells: an attractive source to populate dermal substitutes. Wound Repair Regen 2008, 16:87-94.
108. Hu X., Beeton C. Detection of functional matrix metalloproteinases by zymography. J Vis Exp 2010, 45:2445.
109. Yamanishi H., Fujiwara S., Soma T. Perivascular localization of dermal stem cells in human scalp. Exp Dermatol 2012, 21:78-80.
110. Festa E., Fretz J., Berry R., Schmidt B., Rodeheffer M., Horowitz M., et al. Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell 2011, 146:761-771.
111. Leclerc T., Thepenier C., Jault P., Bey E., Peltzer J., Trouillas M., et al. Cell therapy of burns. Cell Prolif 2011, 44(Suppl. 1):48-54.
112. Coulomb B., Dubertret L., Bell E., Merrill C., Fosse M., Breton-Gorius J., et al. Endogenous peroxidases in normal human dermis: a marker of fibroblast differentiation. J Invest Dermatol 1983, 81:75-78.
113. Miller C.C., Godeau G., Lebreton-DeCoster C., Desmoulière A., Pellat B., Dubertret L., et al. Validation of a morphometric method for evaluating fibroblast numbers in normal and pathologic tissues. Exp Dermatol 2003, 12:403-411.
114. Laco F., Kun M., Weber H.J., Ramakrishna S., Chan C.K. The dose effect of human bone marrow-derived mesenchymal stem cells on epidermal development in organotypic co-culture. J Dermatol Sci 2009, 55:150-160.